Research Options:

Week of Expected Pricing Withdrawn
Company Name BIOVENTUS INC.
Proposed Ticker BIOV
CUSIP 09075A108
Business Description A global medical technology company focused on developing and commercializing innovative and proprietary orthobiologic products for the treatment of patients suffering from a broad array of musculoskeletal conditions.
Lead Underwriter J.P. Morgan Securities LLC,Piper Jaffray & Co.
Co-Managers Leerink Partners LLC,Stifel Nicolaus & Company, Incorporated
Initial Shares 88,23,529
Revised Initial Shares N/A
Initial Price $16.00-$18.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.